Live webinar on the use of generic, biosimilar and non-biologic complex drugs for multiple sclerosis – Second edition – with German translation! Join this webinar and familiarise yourself with the robust European regulatory processes and effective oversight for generic, biosimilar, and follow-on non-biologic complex drugs (NBCDs) of disease modifying therapies in multiple sclerosis. This webinar will allow you to have informed conversations with your patients about the potential use of these agents. Register now Find out more information on the event site here: Webinar...